🇺🇸 FDA
Patent

US 9771376

N-substituted benzamides and methods of use thereof

granted A61KA61K31/18A61K31/397

Quick answer

US patent 9771376 (N-substituted benzamides and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/18, A61K31/397, A61K31/40, A61K31/41